David MacDonald
Directeur Technique/Scientifique/R&D chez XORTX THERAPEUTICS INC.
Postes actifs de David MacDonald
Sociétés | Poste | Début | Fin |
---|---|---|---|
XORTX THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 20/01/2022 | - |
Historique de carrière de David MacDonald
Anciens postes connus de David MacDonald
Sociétés | Poste | Début | Fin |
---|---|---|---|
Immunoflex Therapeutics, Inc. | Directeur Technique/Scientifique/R&D | 01/01/2020 | 01/01/2021 |
Biovail Contract Research Division | Corporate Officer/Principal | - | - |
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
Syntex, Inc. | Corporate Officer/Principal | - | - |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2008 | 01/03/2017 |
President | 01/03/2017 | - | |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Directeur Général | 01/06/2004 | - |
President | 01/06/2004 | - |
Formation de David MacDonald
University of Alberta | Doctorate Degree |
Statistiques
Internationale
Canada | 9 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
President | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
XORTX THERAPEUTICS INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Health Technology |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada. | Health Technology |
Syntex, Inc. | Miscellaneous |
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
Biovail Contract Research Division | Commercial Services |
Immunoflex Therapeutics, Inc. |
- Bourse
- Insiders
- David MacDonald
- Expérience